Valuation Sun Pharma Advanced Research Company Limited

Stocks

Market Closed - NSE India S.E. Other stock markets 04:35:09 09/06/2026 pm IST			5-day change	1st Jan Change
209.19 ^INR	+2.75%		+6.53%	+55.59%

19/05	Sun Pharma Advanced Research says Ocuvex Therapeutics gets complete response letter for PDP-716 NDA	RE
19/05	Sun Pharma Advanced Research Company Limited announced that it has received INR 1.4999645 billion in funding from Shanghvi Finance Pvt Ltd	CI

Data adjusted to current consolidation scope

Fiscal Period: March	2020	2021	2022	2023	2024	2025
Market Cap ¹	25,274	37,250	80,734	58,203	1,19,521	48,000
Change	-	47.38%	116.74%	-27.91%	105.35%	-59.84%
Enterprise Value (EV) ¹	25,869	39,457	81,398	54,335	1,18,562	50,670
Change	-	52.52%	106.3%	-33.25%	118.2%	-57.26%
P/E ratio	-8.09x	-24.6x	-38.4x	-22.9x	-30.9x	-14x
PBR	-136x	-22.1x	259x	11.4x	95x	-22.1x
PEG	-	0.5x	-1.1x	-19.92x	-0.6x	1.2x
Capitalization / Revenue	32.9x	14.7x	58.8x	24.4x	158x	66.9x
EV / Revenue	33.7x	15.6x	59.3x	22.8x	157x	70.6x
EV / EBITDA	-8.42x	-28.9x	-43.4x	-25.3x	-29.5x	-15.6x
EV / EBIT	-8.21x	-27.1x	-41.5x	-24.3x	-28.8x	-15.2x
EV / FCF	-14.7x	-34.9x	-44.4x	-88.9x	-40.4x	-40.2x
FCF Yield	-6.81%	-2.86%	-2.25%	-1.13%	-2.47%	-2.49%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-11.92	-5.768	-7.729	-7.818	-11.93	-10.55
Distribution rate	-	-	-	-	-	-
Net sales ¹	768.1	2,530	1,372	2,388	755.5	717.7
EBITDA ¹	-3,072	-1,366	-1,877	-2,149	-4,023	-3,252
EBIT ¹	-3,150	-1,457	-1,961	-2,236	-4,117	-3,338
Net income ¹	-3,124	-1,511	-2,034	-2,226	-3,872	-3,425
Net Debt ¹	595	2,207	663.2	-3,868	-959.8	2,670
Reference price ²	96.45	142.15	296.95	179.35	368.30	147.91
Nbr of stocks (in thousands)	2,62,048	2,62,048	2,71,879	3,24,522	3,24,522	3,24,522
Announcement Date	07/09/20	07/09/21	30/08/22	14/07/23	18/07/24	18/07/25

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SUN PHARMA ADVANCED RESEARCH COMPANY LIMITED	-	-	-	-	69Cr
ELI LILLY AND COMPANY	33.62x	12.22x	25.16x	0.59%	1,02500Cr
JOHNSON & JOHNSON	24.81x	5.72x	15.56x	2.3%	56TCr
ABBVIE INC.	27.31x	6.66x	13.61x	3.08%	39TCr
ROCHE HOLDING AG	17.31x	4.28x	10.51x	3.11%	32TCr
MERCK & CO., INC.	53.32x	4.96x	20.16x	2.8%	30TCr
ASTRAZENECA PLC	23.32x	4.83x	13.75x	1.81%	29TCr
NOVARTIS AG	20.51x	5.3x	12.89x	3.08%	27TCr
NOVO NORDISK A/S	12.03x	4.53x	9.26x	4.17%	19TCr
AMGEN INC.	22.48x	6.03x	10.53x	2.92%	19TCr
Average	26.08x	6.06x	14.60x	2.65%	35.27TCr
Weighted average by Cap.	28.10x	7.37x	17.10x	2.16%